Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation

NCT ID: NCT04443231

Last Updated: 2020-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-01

Study Completion Date

2019-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To observe the retinal microvascular alteration during 3 months follow-up after Implantable Collamer Lens (ICL) operation in moderate and high myopia patients using quantitative optical coherence tomography angiography (OCTA) analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study object is moderate and high myopia patients, underwent ICL implantation. OCTA was used to image the superficial and deep retinal vascular plexuses before ICL implantation surgery and at 3 months follow-up. OCTA images were corrected for magnification, skeletonized, separated the large vessels and partitioned. Retinal microvascular density was measured by using fractal dimension analysis. The aim of this study was to uncover potential retinal vascular network alterations induced by ICL implantation surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adolescent Adult Human Male Female Follow-up Studies Prospective Studies Lens Implantation, Intraocular Myopia Phakic Intraocular Lenses Retinal Vessels Postoperative Period Preoperative Period Tomography, Optical Coherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Optical Coherence Tomography Angiography

AngioVue (Optovue, Fremont, CA, USA) was used to capture the OCTA images before ICL surgery and at 3 months follow-up.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 45 years old;
* Binocular myopia, with a refraction of greater than -3 diopters (D);
* anterior chamber depth (ACD, measured from the endothelium to the crystalline lens) \> 2.8 mm;
* corneal endothelial cell count (cECC) ≥ 2000 cells/mm2;
* stable refraction at least 1 year before surgery;
* unsatisfactory vision with contact lenses or spectacles.

Exclusion Criteria

* history of intraocular surgery
* other ocular pathology (uveitis, glaucoma, cataract, keratoconus, severe dry eye, etc.)
* other serious systemic disease (diabetes, uncontrolled hypertension, severe hyperthyroidism, etc.).
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hong Qi, PhD, MD

Role: STUDY_DIRECTOR

Peking University Third Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Sanders DR, Doney K, Poco M; ICL in Treatment of Myopia Study Group. United States Food and Drug Administration clinical trial of the Implantable Collamer Lens (ICL) for moderate to high myopia: three-year follow-up. Ophthalmology. 2004 Sep;111(9):1683-92. doi: 10.1016/j.ophtha.2004.03.026.

Reference Type BACKGROUND
PMID: 15350323 (View on PubMed)

Yang Y, Wang J, Jiang H, Yang X, Feng L, Hu L, Wang L, Lu F, Shen M. Retinal Microvasculature Alteration in High Myopia. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6020-6030. doi: 10.1167/iovs.16-19542.

Reference Type RESULT
PMID: 27820633 (View on PubMed)

Li M, Yang Y, Jiang H, Gregori G, Roisman L, Zheng F, Ke B, Qu D, Wang J. Retinal Microvascular Network and Microcirculation Assessments in High Myopia. Am J Ophthalmol. 2017 Feb;174:56-67. doi: 10.1016/j.ajo.2016.10.018. Epub 2016 Nov 4.

Reference Type RESULT
PMID: 27818204 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

tch0101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Berkeley Orthokeratology Study
NCT00000123 COMPLETED PHASE3
The Beijing Childhood Eye Study
NCT06931444 ENROLLING_BY_INVITATION
Endothelial Cell Loss After Penetrating Keratoplasty
NCT04457063 COMPLETED PHASE2/PHASE3